LPCN
Lipocine Inc

14,441
Mkt Cap
$17.62M
Volume
35,759.00
52W High
$5.50
52W Low
$2.52
PE Ratio
-3.10
LPCN Fundamentals
Price
$3.15
Prev Close
$3.17
Open
$3.17
50D MA
$3.02
Beta
0.68
Avg. Volume
54,893.21
EPS (Annual)
-$0.0016
P/B
1.21
Rev/Employee
$699,884.00
Loading...
Loading...
News
all
press releases
News Placeholder
Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in...
PR Newswire·28d ago
News Placeholder
Lipocine (LPCN) Reports Q3 Loss, Tops Revenue Estimates
Lipocine (LPCN) delivered earnings and revenue surprises of -5.36% and +15.00%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025
Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025 Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025 PR Newswire SALT LAKE CITY...
PR Newswire·1mo ago
News Placeholder
Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek
Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek PR Newswire SALT LAKE CITY, Nov. 4, 2025 SALT LAKE CITY, Nov. 4, 2025 /PRNewswire...
PR Newswire·1mo ago
<
...
1
>

Latest LPCN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.